{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2010"],"condition":["Colorectal Carcinoma","Colorectal Tumors","Neoplasms, Colorectal","Colorectal Cancer","Colorectal Neoplasms"],"disease":["Colorectal Carcinoma","Colorectal Tumors","Neoplasms, Colorectal","Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2090309"],"location":["Australia"],"study_start_month":["6"],"keyword":["Irinotecan","Panitumumab","Everolimus"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer","description":"This study will assess the safety of panitumumab, irinotecan and everolimus when given in combination to treat advanced colorectal cancer","dates":{"creation":"2010-06-15"},"accession":"2090309","cross_references":{"ClinicalTrials___gov":["NCT01139138"]}}